Outcomes After Esophagectomy With a Focus on Minimally Invasive Esophagectomy and Quality of Life
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Julie A Ward, BSN
- Phone Number: 412-647-8583
- Email: wardj@upmc.edu
Study Locations
-
-
Pennsylvania
-
Pittsburgh, Pennsylvania, United States, 15232
- Recruiting
- UPMC - Hillman Cancer Center
-
Contact:
- Julie A. Ward, BSN
- Phone Number: 412-647-8583
- Email: wardj@upmc.edu
-
Pittsburgh, Pennsylvania, United States, 15213
- Recruiting
- University of Pittsburgh Medical Center - Department of Cardiothoracic Surgery
-
Sub-Investigator:
- Arjun Pennathur, MD
-
Sub-Investigator:
- Matthew Schuchert, MD
-
Contact:
- Julie A. Ward, BSN
- Phone Number: 412-647-8583
- Email: wardj@upmc.edu
-
Principal Investigator:
- James D. Luketich, MD
-
Sub-Investigator:
- Neil A. Christie, MD
-
Sub-Investigator:
- Ryan Levy, MD
-
Sub-Investigator:
- Omar Awais, DO
-
Sub-Investigator:
- Kevin McGrath, MD
-
Sub-Investigator:
- Tadeusz Witek, MD
-
Sub-Investigator:
- Navid Ajabshir, MD
-
Sub-Investigator:
- Evan Alicuben, MD
-
Sub-Investigator:
- Renee Levesque, MD
-
Sub-Investigator:
- Christian Otero, MD
-
Sub-Investigator:
- James Ackerman, MD
-
Sub-Investigator:
- Thomas Melvin, MD
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients scheduled for MIE (Minimally Invasive Esophagectomy)
- Patients scheduled for open esophagectomy
- Signed informed consent
Exclusion Criteria:
- Patients who are unable to comprehend or complete the QOL instruments.
- Patients less than 18 years of age.
Study Plan
How is the study designed?
Design Details
- Observational Models: Case-Only
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change from baseline in SF36 Quality of Life Questionnaire at 4 month postoperative
Time Frame: Baseline and 4 month postoperative
|
The SF36 is an eight dimension Quality of Life Measurement.
It provides two main Component scores, Physical Component Summary (PCS) and the Mental Component Summary (MCS).
It includes 8 scales or sub-scores: Physical function (PF), role physical (RP), Bodily pain (BP), general health (GH), vitality (VT), social functioning (SF), role emotional (RE), and mental health (MG).
Each scale contributes a different amount to the component scores, which are calculated by a special algorithm that is licensed by Optum.
The Component and sub-scales have a minimum of 0 and a maximum of 100.
The higher the score represent the higher quality of life/less disability.
|
Baseline and 4 month postoperative
|
|
Change from baseline in SF36 Quality of Life Questionnaire at 6 month postoperative
Time Frame: Baseline and 6 month postoperative
|
The SF36 is an eight dimension Quality of Life Measurement.
It provides two main Component scores, Physical Component Summary (PCS) and the Mental Component Summary (MCS).
It includes 8 scales or sub-scores: Physical function (PF), role physical (RP), Bodily pain (BP), general health (GH), vitality (VT), social functioning (SF), role emotional (RE), and mental health (MG).
Each scale contributes a different amount to the component scores, which are calculated by a special algorithm that is licensed by Optum.
The Component and sub-scales have a minimum of 0 and a maximum of 100.
The higher the score represent the higher quality of life/less disability.
|
Baseline and 6 month postoperative
|
|
Change from baseline in SF36 Quality of Life Questionnaire at 12 month postoperative
Time Frame: Baseline and 12 month postoperative
|
The SF36 is an eight dimension Quality of Life Measurement.
It provides two main Component scores, Physical Component Summary (PCS) and the Mental Component Summary (MCS).
It includes 8 scales or sub-scores: Physical function (PF), role physical (RP), Bodily pain (BP), general health (GH), vitality (VT), social functioning (SF), role emotional (RE), and mental health (MG).
Each scale contributes a different amount to the component scores, which are calculated by a special algorithm that is licensed by Optum.
The Component and sub-scales have a minimum of 0 and a maximum of 100.
The higher the score represent the higher quality of life/less disability.
|
Baseline and 12 month postoperative
|
|
Change from baseline in SF36 Quality of Life Questionnaire at 18 month
Time Frame: Baseline and 18 month postoperative
|
The SF36 is an eight dimension Quality of Life Measurement.
It provides two main Component scores, Physical Component Summary (PCS) and the Mental Component Summary (MCS).
It includes 8 scales or sub-scores: Physical function (PF), role physical (RP), Bodily pain (BP), general health (GH), vitality (VT), social functioning (SF), role emotional (RE), and mental health (MG).
Each scale contributes a different amount to the component scores, which are calculated by a special algorithm that is licensed by Optum.
The Component and sub-scales have a minimum of 0 and a maximum of 100.
The higher the score represent the higher quality of life/less disability.
|
Baseline and 18 month postoperative
|
|
Change from baseline in SF36 Quality of Life Questionnaire at 24 month
Time Frame: Baseline and 24 month postoperative
|
The SF36 is an eight dimension Quality of Life Measurement.
It provides two main Component scores, Physical Component Summary (PCS) and the Mental Component Summary (MCS).
It includes 8 scales or sub-scores: Physical function (PF), role physical (RP), Bodily pain (BP), general health (GH), vitality (VT), social functioning (SF), role emotional (RE), and mental health (MG).
Each scale contributes a different amount to the component scores, which are calculated by a special algorithm that is licensed by Optum.
The Component and sub-scales have a minimum of 0 and a maximum of 100.
The higher the score represent the higher quality of life/less disability.
|
Baseline and 24 month postoperative
|
|
Change from baseline in SF36 Quality of Life Questionnaire at 30 month
Time Frame: Baseline and 30 month postoperative
|
The SF36 is an eight dimension Quality of Life Measurement.
It provides two main Component scores, Physical Component Summary (PCS) and the Mental Component Summary (MCS).
It includes 8 scales or sub-scores: Physical function (PF), role physical (RP), Bodily pain (BP), general health (GH), vitality (VT), social functioning (SF), role emotional (RE), and mental health (MG).
Each scale contributes a different amount to the component scores, which are calculated by a special algorithm that is licensed by Optum.
The Component and sub-scales have a minimum of 0 and a maximum of 100.
The higher the score represent the higher quality of life/less disability.
|
Baseline and 30 month postoperative
|
|
Change from baseline in SF36 Quality of Life Questionnaire at 36 month
Time Frame: Baseline and 36 month postoperative
|
The SF36 is an eight dimension Quality of Life Measurement.
It provides two main Component scores, Physical Component Summary (PCS) and the Mental Component Summary (MCS).
It includes 8 scales or sub-scores: Physical function (PF), role physical (RP), Bodily pain (BP), general health (GH), vitality (VT), social functioning (SF), role emotional (RE), and mental health (MG).
Each scale contributes a different amount to the component scores, which are calculated by a special algorithm that is licensed by Optum.
The Component and sub-scales have a minimum of 0 and a maximum of 100.
The higher the score represent the higher quality of life/less disability.
|
Baseline and 36 month postoperative
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: James D Luketich, MD, UPMC - Department of Cardiothoracic Surgery
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimated)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Neoplasms by Site
- Neoplasms
- Gastrointestinal Neoplasms
- Digestive System Neoplasms
- Digestive System Diseases
- Gastrointestinal Diseases
- Head and Neck Neoplasms
- Esophageal Diseases
- Esophageal Neoplasms
- Health Care Quality, Access, and Evaluation
- Investigative Techniques
- Epidemiologic Methods
- Data Collection
- Health Care Evaluation Mechanisms
- Quality of Health Care
- Public Health
- Environment and Public Health
- Surveys and Questionnaires
Other Study ID Numbers
Other Study ID Numbers
- STUDY20040382
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.